Literature DB >> 20568248

Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.

Andrea Piccin, Sergio Cortelazzo, Ugo Rovigatti, Billy Bourke, Owen P Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568248     DOI: 10.1002/ajh.21755

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Azathioprine-associated myelodysplastic syndrome in two patients with ulcerative colitis.

Authors:  Omer F Ahmad; Margaret G Keane; Sara McCartney; Asim Khwaja; Stuart L Bloom
Journal:  Frontline Gastroenterol       Date:  2013-03-20

Review 2.  Treatment of Crohn's disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review.

Authors:  Changmei Hu; Liang Lv; Deliang Liu; Jirong Huo
Journal:  Clin J Gastroenterol       Date:  2014-05-22

3.  Iatrogenic Coagulopathy and the Development of Posterior Reversible Encephalopathy Syndrome after L-asparaginase Chemotherapy.

Authors:  Eugenia Rota; Daniele Vallisa; Nicola Morelli; Paola Scagnelli
Journal:  J Clin Imaging Sci       Date:  2016-02-26

4.  Allogeneic hematopoietic stem cell transplantation for Crohn disease complicated with myelodysplastic syndrome: A case report.

Authors:  Ying Zhang; Li-Li Lou; Xiao-Dong Shi; Sha-Sha Lu; Li-Xia Zhang; Xu Huang; Hui-Fan Ji; Xu Li; Xiao-Lin Guo
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.